IOVS Journal of Neuroscience
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.
(Investigative Ophthalmology and Visual Science. 2000;41:2702-2706.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

PKC-ß Inhibitor (LY333531) Attenuates Leukocyte Entrapment in Retinal Microcirculation of Diabetic Rats

Atsushi Nonaka1, Junichi Kiryu1, Akitaka Tsujikawa1, Kenji Yamashiro1, Kazuaki Miyamoto1, Hirokazu Nishiwaki1, Yoshihito Honda1 and Yuichiro Ogura2

1 From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; and 2 Department of Ophthalmology, Nagoya City University Medical School, Nagoya, Japan.

PURPOSE. The activity of protein kinase C (PKC), preferentially ß isoform of PKC, has been shown to be elevated in the diabetic retina. Recently, LY333531, a specific inhibitor of PKC-ß, has been reported to improve the decrease of retinal blood flow in early diabetes. Increased leukocyte entrapment has been suggested to be involved in blood flow disturbances in the early diabetic retina. This study was designed quantitatively to evaluate leukocyte entrapment in the retinal microcirculation of diabetic rats and the effect of LY333531 on leukocyte entrapment.

METHODS. Diabetes was induced in male Long-Evans rats by intraperitoneal injection of streptozotocin (60 mg/kg). LY333531 (0.1, 1.0, or 10.0 mg/kg/d) was administered orally during a 4-week diabetic period. Leukocyte entrapment in the retinal microcirculation was quantitatively evaluated in vivo with acridine orange digital fluorography.

RESULTS. The number of leukocytes trapped in the retinal microcirculation of diabetic rats (mean ± SEM; 14.3 ± 1.3 cells/mm2) was significantly increased, compared with nondiabetic control rats (7.5 ± 0.3 cells/mm2; P < 0.0001). Oral administration of LY333531 significantly decreased the number of leukocytes trapped in the retinal microcirculation of diabetic rats (10.9 ± 0.6, 11.3 ± 0.7, and 10.4 ± 0.4 cells/mm2 with LY333531 0.1, 1.0, and 10.0 mg/kg/d, respectively; P < 0.05).

CONCLUSIONS. Treatment with LY333531 attenuated the increase of leukocyte entrapment in the retinal microcirculation during the period of early diabetes. This effect may contribute to the improvement of abnormal retinal blood flow in early diabetes with LY333531. LY333531 might have a therapeutic efficacy in preventing microcirculatory flow disturbances by trapped leukocytes in the early diabetic retina.




This article has been cited by other articles:


Home page
IOVSHome page
Y. Kaji, T. Usui, S. Ishida, K. Yamashiro, T. C. B. Moore, J. Moore, Y. Yamamoto, H. Yamamoto, and A. P. Adamis
Inhibition of Diabetic Leukostasis and Blood-Retinal Barrier Breakdown with a Soluble Form of a Receptor for Advanced Glycation End Products
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Zhou, X.-L. Wang, K. G. Lamping, and H.-C. Lee
Inhibition of Protein Kinase Cbeta Protects against Diabetes-Induced Impairment in Arachidonic Acid Dilation of Small Coronary Arteries
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. P. Aiello, A. Clermont, V. Arora, M. D. Davis, M. J. Sheetz, and S.-E. Bursell
Inhibition of PKC {beta} by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in Patients
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 86 - 92.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. M. Ben-Mahmud, G. E. Mann, A. Datti, A. Orlacchio, E. M. Kohner, and R. Chibber
Tumor Necrosis Factor-{alpha} in Diabetic Plasma Increases the Activity of Core 2 GlcNAc-T and Adherence of Human Leukocytes to Retinal Endothelial Cells: Significance of Core 2 GlcNAc-T in Diabetic Retinopathy
Diabetes, November 1, 2004; 53(11): 2968 - 2976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Miyahara, J. Kiryu, K. Yamashiro, K. Miyamoto, F. Hirose, H. Tamura, H. Katsuta, K. Nishijima, A. Tsujikawa, and Y. Honda
Simvastatin Inhibits Leukocyte Accumulation and Vascular Permeability in the Retinas of Rats with Streptozotocin-Induced Diabetes
Am. J. Pathol., May 1, 2004; 164(5): 1697 - 1706.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M R Stanford
The pathogenesis of diabetic retinopathy
Br. J. Ophthalmol., April 1, 2004; 88(4): 444 - 445.
[Full Text] [PDF]


Home page
IOVSHome page
H. Luan, M. Leitges, R. R. Gupta, D. Pacheco, A. Seidner, J. Liggett, Y. Ito, R. Kowluru, and B. A. Berkowitz
Effect of PKC{beta} on Retinal Oxygenation Response in Experimental Diabetes
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
R Donnelly, I Idris, and J V Forrester
Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
Br. J. Ophthalmol., January 1, 2004; 88(1): 145 - 151.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Yu, I. Morita, K. Shimokado, T. Iwai, and M. Yoshida
Amlodipine Modulates THP-1 Cell Adhesion to Vascular Endothelium via Inhibition of Protein Kinase C Signal Transduction
Hypertension, September 1, 2003; 42(3): 329 - 334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Chibber, B. M. Ben-Mahmud, G. E. Mann, J. J. Zhang, and E. M. Kohner
Protein Kinase C {beta}2-Dependent Phosphorylation of Core 2 GlcNAc-T Promotes Leukocyte-Endothelial Cell Adhesion: A Mechanism Underlying Capillary Occlusion in Diabetic Retinopathy
Diabetes, June 1, 2003; 52(6): 1519 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
Z. He, C. Rask-Madsen, and G.L. King
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57.
[Abstract] [PDF]


Home page
JAMAHome page
M. J. Sheetz and G. L. King
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
JAMA, November 27, 2002; 288(20): 2579 - 2588.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida
Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats
Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Booth, T. J. Stalker, A. M. Lefer, and R. Scalia
Mechanisms of Amelioration of Glucose-Induced Endothelial Dysfunction Following Inhibition of Protein Kinase C In Vivo
Diabetes, May 1, 2002; 51(5): 1556 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. T. Rosenbaum
Sugar Creates a Sticky Business: Round Up the Usual Suspects
Am. J. Pathol., May 1, 2002; 160(5): 1547 - 1550.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology